🐺 Research stack recovery

The Wolverine Stack

BPC-157 and TB-500 are two of the most researched recovery peptides available. Combined, they target tissue repair through complementary mechanisms — one focusing on tendon and gut healing, the other on muscle and angiogenesis. This is why researchers study them together.

🩹 BPC-157 🩹 TB-500
What this stack is studied for
  • Accelerated tendon and ligament repair
  • Gut lining protection and healing
  • Reduced systemic inflammation
  • New blood vessel formation at injury sites
  • Complementary mechanisms — broader healing coverage
BPC-157 Research peptide
TB-500 Research peptide
COA Purity certified vendors only
5 Markets covered

What is The Wolverine Stack?

BPC-157 + TB-500 — why combine them?

The Wolverine Stack is an informal name used in the research community for the combination of BPC-157 and TB-500. The name comes from the Marvel character known for accelerated healing — which is exactly what these compounds are studied for.

Neither compound is approved for therapeutic use. Both have extensive preclinical research — primarily in rodent models — showing accelerated healing of tendons, ligaments, muscles and gut tissue. No completed human clinical trials exist for either in this combined form.

Why combine them?

BPC-157 and TB-500 work through different biological pathways. BPC-157 primarily promotes tendon attachment and gut protection. TB-500 regulates actin and drives angiogenesis. Together, they cover more of the healing cascade than either alone — which is why researchers combine them.

Plain English

What this means for you

If you are researching compounds for injury recovery — tendons, ligaments, muscle tears, or gut issues — BPC-157 and TB-500 are the two most studied peptides for this purpose.

Think of BPC-157 as the specialist for tendon attachment and gut lining repair. TB-500 is more systemic — it promotes new blood vessel formation and reduces inflammation across the body.

Combined, they cover different parts of the recovery process — which is why they are commonly studied together rather than separately.

The compounds

What's in this stack

BPC-157🩹
BPC-157
Synthetic pentadecapeptide with extensive preclinical research in tissue repair and regeneration
Reported benefits
Accelerated tendon and ligament healing in animal models
Gut lining repair and gastroprotection
Reduced inflammation at injury sites
Muscle tear recovery support
Full BPC-157 research guide →
TB-500🩹
TB-500
Synthetic thymosin beta-4 fragment studied for tissue repair, wound healing and inflammation
Reported benefits
Faster tendon and ligament repair
Reduced inflammation at injury sites
Improved wound healing
Promotes new blood vessel formation
Full TB-500 research guide →

Why they work together

Complementary mechanisms

01
Different pathways
BPC-157 works through growth hormone receptor upregulation and nitric oxide pathways. TB-500 works through actin regulation. They do not compete — they complement.
02
Broader coverage
BPC-157 specialises in tendon attachment and gut tissue. TB-500 is more systemic — promoting healing across muscle, connective tissue and blood vessel formation.
03
Research basis
The combination is widely studied in animal models. Each compound has substantial independent preclinical literature supporting the rationale for combining them.

Source this stack

Where are you based?

Select your market to see COA-verified vendors for both compounds. We only list vendors with third-party purity certification.

🇦🇺 Australia — TGA
✓ Legal for research Both compounds unscheduled under TGA. Legal for research without a prescription.
🩹 BPC-157 COA verified

Available from verified vendors. Click to view options for your selected market.

View BPC-157 vendors →
🩹 TB-500 COA verified

Available from verified vendors. Click to view options for your selected market.

View TB-500 vendors →